| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.066 | 0.06 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.1 | 0.06 |
| mRNA | NSC-87877 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.07 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.07 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.11 | 0.07 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | -0.056 | 0.07 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.063 | 0.07 |